NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

Abstract Background Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain, fever, and inflammation but have been associated with complications in community-acquired pneumonia. Observations shortly after the start of the COVID-19 pandemic in 2020 suggested that ibuprofen was...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Justin T. Reese, Ben Coleman, Lauren Chan, Hannah Blau, Tiffany J. Callahan, Luca Cappelletti, Tommaso Fontana, Katie R. Bradwell, Nomi L. Harris, Elena Casiraghi, Giorgio Valentini, Guy Karlebach, Rachel Deer, Julie A. McMurry, Melissa A. Haendel, Christopher G. Chute, Emily Pfaff, Richard Moffitt, Heidi Spratt, Jasvinder A. Singh, Christopher J. Mungall, Andrew E. Williams, Peter N. Robinson
Format: Artigo
Jezik:Inglês
Izdano: BMC 2022-05-01
Serija:Virology Journal
Teme:
COVID-19
NSAIDs
Cyclooxygenase inhibitors
Observational study
Online dostop:https://doi.org/10.1186/s12985-022-01813-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki